22nd Century Total Liabilities and Share Holders Equity 2011-2024 | XXII
22nd Century total liabilities and share holders equity from 2011 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
22nd Century Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2023 |
$28 |
| 2022 |
$115 |
| 2021 |
$76 |
| 2020 |
$52 |
| 2019 |
$69 |
| 2018 |
$77 |
| 2017 |
$80 |
| 2016 |
$28 |
| 2015 |
$18 |
| 2014 |
$22 |
| 2013 |
$12 |
| 2012 |
$3 |
| 2011 |
$2 |
| 2010 |
$3 |
22nd Century Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024-09-30 |
$26 |
| 2024-06-30 |
$24 |
| 2024-03-31 |
$25 |
| 2023-12-31 |
$28 |
| 2023-09-30 |
$64 |
| 2023-06-30 |
$125 |
| 2023-03-31 |
$124 |
| 2022-12-31 |
$115 |
| 2022-09-30 |
$142 |
| 2022-06-30 |
$119 |
| 2022-03-31 |
$66 |
| 2021-12-31 |
$76 |
| 2021-09-30 |
$86 |
| 2021-06-30 |
$97 |
| 2021-03-31 |
$60 |
| 2020-12-31 |
$52 |
| 2020-09-30 |
$57 |
| 2020-06-30 |
$61 |
| 2020-03-31 |
$64 |
| 2019-12-31 |
$69 |
| 2019-09-30 |
$62 |
| 2019-06-30 |
$71 |
| 2019-03-31 |
$77 |
| 2018-12-31 |
$77 |
| 2018-09-30 |
$86 |
| 2018-06-30 |
$79 |
| 2018-03-31 |
$83 |
| 2017-12-31 |
$80 |
| 2017-09-30 |
$32 |
| 2017-06-30 |
$29 |
| 2017-03-31 |
$25 |
| 2016-12-31 |
$28 |
| 2016-09-30 |
$20 |
| 2016-06-30 |
$18 |
| 2016-03-31 |
$21 |
| 2015-12-31 |
$18 |
| 2015-09-30 |
$21 |
| 2015-06-30 |
$23 |
| 2015-03-31 |
$18 |
| 2014-12-31 |
$22 |
| 2014-09-30 |
$27 |
| 2014-06-30 |
$11 |
| 2014-03-31 |
$12 |
| 2013-12-31 |
$12 |
| 2013-09-30 |
$4 |
| 2013-06-30 |
$3 |
| 2013-03-31 |
$3 |
| 2012-12-31 |
$3 |
| 2012-09-30 |
$3 |
| 2012-06-30 |
$3 |
| 2012-03-31 |
$2 |
| 2011-12-31 |
$2 |
| 2011-09-30 |
$2 |
| 2011-06-30 |
$3 |
| 2011-03-31 |
$3 |
| 2010-12-31 |
$3 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.004B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
